OTHER INCOME (Tables)

3 Months Ended

Mar. 31, 2020

Other Income and Expenses [Abstract]

Schedule of Other Income

	Three months ended March 31
(In millions)	2020			2019
Purchases and sales of business interests(a)	$	12,372		$	253
Licensing and royalty income	42			40
Associated companies	39			39
Net interest and investment income(b)	(5,632		)	137
Other items	53			384
GE	6,874			852
Eliminations	(4		)	(5		)
Total	$	6,869		$	847

(a) Included a pre-tax gain of $12,292 million on the sale of BioPharma in 2020. Included a pre-tax gain of $224 million on the sale of ServiceMax in 2019. See Note 2 for further information.

(b)

Included unrealized loss of $(5,710) million related to our interest in Baker Hughes in 2020. See Note 3 for further information.